Presence and Comparison of Sarcopenia in Early Rheumatoid Arthritis and Rheumatoid Arthritis
NCT ID: NCT06284200
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
48 participants
OBSERVATIONAL
2023-06-23
2024-06-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Materials and Method: According to the power analysis, 24 patients with early rheumatoid arthritis and 24 patients with established rheumatoid arthritis who meet the 2010 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) rheumatoid arthritis (RA) classification criteria will be included in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rheumatoid Arthritis and Osteosarcopenia: Associated Factors
NCT06889415
Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis
NCT06437392
Investigation Of The Effects Of Anti-Tnf-Α And Non-Tnf-Α Drugs İn Patients With Rheumatoid Arthritis
NCT07182630
Effect of Quadriceps Muscle on Physical Outcome Measures in Women With Rheumatoid Arthritis
NCT06197074
Fatigue in Patients With Rheumatoid Arthritis
NCT05996705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being 18 years or older
* Being followed up with a diagnosis of RA for less than 1 year (early RA)
* To be diagnosed with RA according to the 2010 ACR (American Society for the Study of Rheumatism) / EULAR (European Association for the Study of Rheumatism) RA classification criteria
* Being 18 years or older
Exclusion Criteria
* Presence of malnutrition
* Recent surgical history,
* Stroke history,
* Pregnancy,
* Presence of prosthesis or metal implant,
* Presence of a pacemaker,
* Patients over 140 kg
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kayseri City Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Havva Talay Çalış
Prof. Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
HAVVA TALAY ÇALIŞ, PROF
Role: STUDY_DIRECTOR
Health Sciences University, Kayseri Medical Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Sciences University, Kayseri Medicine Faculty
Kocasinan, Kayseri, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
sarcopenia eRA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.